Nuvasive Inc. has received expanded 510(k) clearance for its Precice platform, which could allow the company to have a deeper reach into the limb lengthening and trauma markets. The expanded indication is one of several key drivers in the San Francisco-based company's growth that have occurred in the past few months. Read More
